- GSK (GS71 TH) +11%
- Zantac Cases Tossed After Judge Rejects Cancer-Link Evidence
- Sanofi (SNW TH) +7.2%
- Zantac Cases Tossed After Judge Rejects Cancer-Link Evidence
- Haleon (H6D0 TH) +4.8%
- Novozymes (NZM2 TH) +2.7%
- JPM Upgrades Novozymes, Cuts Umicore Among European Chemicals
- Vodafone (VODI TH) +1.8%
- Rio Tinto (RIO1 TH) +1%
- Nel (D7G TH) -1.2%
- Hugo Boss (BOSS TH) -1.3%
- Aixtron (AIXA TH) -1.3%
- Shell (R6C0 TH) -1.3%
- Equinor (DNQ TH) -1.6%
- Air Liquide (AIL TH) -1.6%
- Alstom (AOMD TH) -1.9%
- MS Prefers Defensive Capital Goods Names, Cuts Three Stocks
- Airbus (AIR TH) -2.1%
- Airbus Looks to Finally Beat Boeing With New Jet to Rival 737
- Umicore (NVJP TH) -3.1%
- JPM Upgrades Novozymes, Cuts Umicore Among European Chemicals
- Terna (UEI TH) -4.2%
- Terna Cut as Morgan Stanley Sees Too Much Growth Priced In